Disrupting VEGF–VEGFR1 Interaction: De Novo Designed Linear Helical Peptides to Mimic the VEGF13-25 Fragment

The interaction between vascular endothelial growth factor (VEGF) and its receptors (VEGFR) has important implications in angiogenesis and cancer, which moved us to search for peptide derivatives able to block this protein–protein interaction. In a previous work we had described a collection of line...

Full description

Bibliographic Details
Main Authors: Beatriz Balsera, M. Ángeles Bonache, Marie Reille-Seroussi, Nathalie Gagey-Eilstein, Michel Vidal, Rosario González-Muñiz, María Jesús Pérez de Vega
Format: Article
Language:English
Published: MDPI AG 2017-10-01
Series:Molecules
Subjects:
Online Access:https://www.mdpi.com/1420-3049/22/11/1846
_version_ 1819267061594980352
author Beatriz Balsera
M. Ángeles Bonache
Marie Reille-Seroussi
Nathalie Gagey-Eilstein
Michel Vidal
Rosario González-Muñiz
María Jesús Pérez de Vega
author_facet Beatriz Balsera
M. Ángeles Bonache
Marie Reille-Seroussi
Nathalie Gagey-Eilstein
Michel Vidal
Rosario González-Muñiz
María Jesús Pérez de Vega
author_sort Beatriz Balsera
collection DOAJ
description The interaction between vascular endothelial growth factor (VEGF) and its receptors (VEGFR) has important implications in angiogenesis and cancer, which moved us to search for peptide derivatives able to block this protein–protein interaction. In a previous work we had described a collection of linear 13-mer peptides specially designed to adopt helical conformations (Ac-SSEEX5ARNX9AAX12N-NH2), as well as the evaluation of seven library components for the inhibition of the interaction of VEGF with its Receptor 1 (VEGFR1). This study led to the discovery of some new, quite potent inhibitors of this protein–protein system. The results we found prompted us to extend the study to other peptides of the library. We describe here the evaluation of a new selection of peptides from the initial library that allow us to identify new VEGF-VEGFR1 inhibitors. Among them, the peptide sequence containing F, W, and I residues at the 5, 9, and 12 positions, show a very significant nanomolar IC50 value, competing with VEGF for its receptor 1, VEGFR1 (Flt-1), which could represent a new tool within the therapeutic arsenal for cancer detection and therapy.
first_indexed 2024-12-23T21:11:11Z
format Article
id doaj.art-b5119049a937466c95286b63caa9caaf
institution Directory Open Access Journal
issn 1420-3049
language English
last_indexed 2024-12-23T21:11:11Z
publishDate 2017-10-01
publisher MDPI AG
record_format Article
series Molecules
spelling doaj.art-b5119049a937466c95286b63caa9caaf2022-12-21T17:31:03ZengMDPI AGMolecules1420-30492017-10-012211184610.3390/molecules22111846molecules22111846Disrupting VEGF–VEGFR1 Interaction: De Novo Designed Linear Helical Peptides to Mimic the VEGF13-25 FragmentBeatriz Balsera0M. Ángeles Bonache1Marie Reille-Seroussi2Nathalie Gagey-Eilstein3Michel Vidal4Rosario González-Muñiz5María Jesús Pérez de Vega6Instituto de Química-Médica (IQM-CSIC), Juan de la Cierva 3, Madrid 28006, SpainInstituto de Química-Médica (IQM-CSIC), Juan de la Cierva 3, Madrid 28006, SpainUMR 8638 CNRS, UFR de Pharmacie, Université Paris Descartes, PRES Sorbonne Paris Cité, 4 avenue de l’Observatoire, Paris 75006, FranceUMR 8638 CNRS, UFR de Pharmacie, Université Paris Descartes, PRES Sorbonne Paris Cité, 4 avenue de l’Observatoire, Paris 75006, FranceUMR 8638 CNRS, UFR de Pharmacie, Université Paris Descartes, PRES Sorbonne Paris Cité, 4 avenue de l’Observatoire, Paris 75006, FranceInstituto de Química-Médica (IQM-CSIC), Juan de la Cierva 3, Madrid 28006, SpainInstituto de Química-Médica (IQM-CSIC), Juan de la Cierva 3, Madrid 28006, SpainThe interaction between vascular endothelial growth factor (VEGF) and its receptors (VEGFR) has important implications in angiogenesis and cancer, which moved us to search for peptide derivatives able to block this protein–protein interaction. In a previous work we had described a collection of linear 13-mer peptides specially designed to adopt helical conformations (Ac-SSEEX5ARNX9AAX12N-NH2), as well as the evaluation of seven library components for the inhibition of the interaction of VEGF with its Receptor 1 (VEGFR1). This study led to the discovery of some new, quite potent inhibitors of this protein–protein system. The results we found prompted us to extend the study to other peptides of the library. We describe here the evaluation of a new selection of peptides from the initial library that allow us to identify new VEGF-VEGFR1 inhibitors. Among them, the peptide sequence containing F, W, and I residues at the 5, 9, and 12 positions, show a very significant nanomolar IC50 value, competing with VEGF for its receptor 1, VEGFR1 (Flt-1), which could represent a new tool within the therapeutic arsenal for cancer detection and therapy.https://www.mdpi.com/1420-3049/22/11/1846peptidesα-helixprotein–protein interactionsVEGF-VEGFR1angiogenesis
spellingShingle Beatriz Balsera
M. Ángeles Bonache
Marie Reille-Seroussi
Nathalie Gagey-Eilstein
Michel Vidal
Rosario González-Muñiz
María Jesús Pérez de Vega
Disrupting VEGF–VEGFR1 Interaction: De Novo Designed Linear Helical Peptides to Mimic the VEGF13-25 Fragment
Molecules
peptides
α-helix
protein–protein interactions
VEGF-VEGFR1
angiogenesis
title Disrupting VEGF–VEGFR1 Interaction: De Novo Designed Linear Helical Peptides to Mimic the VEGF13-25 Fragment
title_full Disrupting VEGF–VEGFR1 Interaction: De Novo Designed Linear Helical Peptides to Mimic the VEGF13-25 Fragment
title_fullStr Disrupting VEGF–VEGFR1 Interaction: De Novo Designed Linear Helical Peptides to Mimic the VEGF13-25 Fragment
title_full_unstemmed Disrupting VEGF–VEGFR1 Interaction: De Novo Designed Linear Helical Peptides to Mimic the VEGF13-25 Fragment
title_short Disrupting VEGF–VEGFR1 Interaction: De Novo Designed Linear Helical Peptides to Mimic the VEGF13-25 Fragment
title_sort disrupting vegf vegfr1 interaction de novo designed linear helical peptides to mimic the vegf13 25 fragment
topic peptides
α-helix
protein–protein interactions
VEGF-VEGFR1
angiogenesis
url https://www.mdpi.com/1420-3049/22/11/1846
work_keys_str_mv AT beatrizbalsera disruptingvegfvegfr1interactiondenovodesignedlinearhelicalpeptidestomimicthevegf1325fragment
AT mangelesbonache disruptingvegfvegfr1interactiondenovodesignedlinearhelicalpeptidestomimicthevegf1325fragment
AT mariereilleseroussi disruptingvegfvegfr1interactiondenovodesignedlinearhelicalpeptidestomimicthevegf1325fragment
AT nathaliegageyeilstein disruptingvegfvegfr1interactiondenovodesignedlinearhelicalpeptidestomimicthevegf1325fragment
AT michelvidal disruptingvegfvegfr1interactiondenovodesignedlinearhelicalpeptidestomimicthevegf1325fragment
AT rosariogonzalezmuniz disruptingvegfvegfr1interactiondenovodesignedlinearhelicalpeptidestomimicthevegf1325fragment
AT mariajesusperezdevega disruptingvegfvegfr1interactiondenovodesignedlinearhelicalpeptidestomimicthevegf1325fragment